Cardiac procedures & devices × cardiovascular events

TrialCirculation. Cardiovascular quality and outcomes2009

Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER).

Paul M Ridker et al.PubMed ↗Publisher ↗

What the trial testedrandomised · 2009

Randomised comparison

Probably increased cardiovascular events

+20.0+14.0 to +34.0

As reported

NNT 20, 95% CI 14.0–34.0

One number in the abstract

the abstract, start to end

death, the 5-year NNT within JUPITER was 20 (95% CI, 14 to 34).

← favours treatmentfavours comparator →
could be chance
Cardiovascular events
NNT 2014.0–34.0
Cardiac procedures & devicesCardiovascular events

Cardiac procedures & devices × cardiovascular eventshelps?mixed

unlikelylikely
0.500.50 without it
← favours treatmentfavours comparator →
this papermore certainless certain
1 / 5

47 papers cite it

2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this paperpooled ittrialcites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 20031900